PCVX
Vaxcyte, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +25.0% ·
share flow +18.9% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | +1 | 85.77M | $4.99B | +6 | −4 |
| Q1 2026 | 115 | +4 | 93.55M | $5.43B | +8 | −5 |
| Q4 2025 | 111 | 0 | 92.90M | $4.29B | +2 | −1 |
| Q3 2025 | 18 | +2 | 60.74M | $2.19B | +3 | −2 |
| Q2 2025 | 14 | 0 | 57.50M | $1.87B | +1 | −1 |
| Q1 2025 | 11 | -1 | 19.96M | $753.77M | — | −1 |
| Q4 2024 | 12 | +1 | 18.46M | $1.51B | +1 | — |
| Q3 2024 | 10 | +2 | 13.93M | $1.59B | +3 | −1 |
| Q2 2024 | 8 | — | 11.72M | $885.19M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 4.47M | +40.8% | $510.35M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 4.47M | +40.8% | $510.35M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passive) | 2.70M | +10.6% | $308.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passive) | 2.70M | +10.6% | $308.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Norges Bank ✦ (passive) | 1.11M | +13.0% | $127.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 423.50K | +84.0% | $48.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 359.80K | New | $41.11M | 0.1% | New | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 298.44K | +46.5% | $34.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Duquesne Family Office ✦ | 42.97K | New | $4.91M | 0.2% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 11.11K | +2.3% | $1.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 11.11K | +2.3% | $1.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 5.87K | New | $670,422 | 0.0% | New | 1 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 5.87K | New | $670,422 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $41.11M | 0.1% |
| Duquesne Family Office | $4.91M | 0.2% |
| Citadel Advisors | $670,422 | 0.0% |
| Citadel Advisors | $670,422 | 0.0% |
Exited
| Adage Capital Partners | $6.42M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 53.30K shares, $3,097 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.